You are here

Molecular, Cell, and Tissue Engineering

The department's efforts in the area of Cell/Tissue Engineerng are directed towards both disease-driven research and the development enabling technologies. Disease-driven research includes improvement of clinically used tissue-engineered skin and tissue-engineered islets for potential treatment of type-I diabetes. Development of enabling technologies include new strategies for drug delivery, cell and tissue cryopreservation, self-assembling the extra-cellular matrix and biomimetic technologies.